Programme to improve the use of beta-blockers for heart failure in the elderly and in those with severe symptoms: Results of the BRING-UP 2 Study

European Journal of Heart Failure

Volumn 8, Issue 6, 2006, Pages 649-657

  Opasich, Cristina ^a   Boccanelli, Alessandro ^b   Cafiero, Massimo ^c   Cirrincione, Vincenzo ^d   Sindaco, Donatella Del ^e   Lenarda, Andrea Di ^f   Luzio, Silvia Di ^g   Faggiano, Pompilio ^h   Frigerio, Maria ⁱ   Lucci, Donata ^j   Porcu, Maurizio ^k   Pulignano, Giovanni ^l   Scherillo, Marino ^m   Tavazzi, Luigi ⁿ   Maggioni, Aldo P ^j  

^a IRCCS   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Clinic Center   (Italy)

^d Cardiology Unit   (Italy)

^e INRCA   (Italy)

^f UNIVERSITY OF TRIESTE   (Italy)

^g SPIRITO SANTO HOSPITAL   (Italy)

^h Spedali Civili ^*  (Italy)

ⁱ OSPEDALE NIGUARDA CA GRANDA   (Italy)

^j ANMCO RESEARCH CENTER   (Italy)

^k BROTZU HOSPITAL   (Italy)

^l SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^m G RUMMO HOSPITAL   (Italy)

ⁿ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

more..

Author keywords

Beta blockers; Elderly; Heart failure

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; CARBAZOLES; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; PROPANOLAMINES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 33750044287     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.11.005     Document Type: Article

References (23)

1. Packer M., Bristow M.R., Cohn J.N., et al., U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
2. The MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
3. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
4. Packer M., Coats A.J., Fowler M.B., et al., Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 (2001) 1651-1658
5. Ansari M., Alexander M., Tutar A., Bello D., and Massie B.M. Cardiology partecipation improves outcomes in patients with new onset heart failure in the outpatient setting. J Am Coll Cardiol 41 (2003) 62-68
6. The Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart failure survey programme-a survey on the quality of care among patients with heart failure in Europe: Part 2. Treatment. Eur Heart J 24 (2003) 464-475
7. Maggioni A.P., Sinagra G., Opasich C., et al. Beta-blockers in patients with congestive heart failure: guided use in clinical practice Investigators. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 89 (2003) 299-305
8. Packer M., Fowler M., Roecker E., et al., Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure. Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Circulation 106 (2002) 2194-2199
9. Goldstein S., Fagerberg B., Hjalmarson A., et al., MERIT-HF Study Group. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study. J Am Coll Cardiol 38 (2001) 932-938
10. Flather M.D., Shibata M.C., Coats A.J., et al., SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
11. Pulignano G., Del Sindaco D., Tavazzi L., et al., IN-CHF Investigators. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 143 (2002) 45-55
12. Cleland J.G., Cohen-Solal A., Aguilar J.C., et al., IMPROVEMENT of Heart Failure Programme Committees and Investigators. Improvement programme in evaluation and management; Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360 (2002) 1631-1639
13. Lien C.T., Gillespie N.D., Struthers A.D., and McMurdo M.E. Heart failure in frail elderly patients: diagnostic difficulties, co-morbidities, polipharmacy and treatment dilemmas. Eur J Heart Fail 4 (2002) 91-98
14. Baxter A.J., Spensley A., Hildreth A., Karimova G., O'Connell J.E., and Gray C.S. Beta-blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 88 (2002) 611-614
15. Sin D.D., and McAlister F.A. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 113 (2002) 650-656
16. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 127 (2002) 715-725
17. Haas S.J., Vos T., Gilbert R.E., and Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 146 (2003) 848-853
18. Bobbio M., Ferrua S., Opasich C., et al., BRING-UP Investigators. Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers. J Cardiac Fail 9 (2003) 192-202
19. Erdmann E., Lechat P., Verkenne P., and Wiemann H. Results from post hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail 3 (2001) 469-479
20. Bouzamondo A., Hulot J.S., Sanchez P., and Lechat P. Beta-blocker benefit according to severity of heart failure. Eur J Heart Fail 5 (2003) 281-289
21. Wedel H., Demets D., Deedwania P., et al. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Am Heart J 142 (2001) 502-511
22. Ansari M., Shlipak M.G., Heidenreich P.A., et al. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation 107 (2003) 2799-2804
23. Gattis W.A., O'Connor C.M., Gallup D.S., Hasselblad V., Gheorghiade M., and IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol 43 (2004) 1534-1541